Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.
Bhavana KondaEric J ShermanErminia MassarelliJorge NievaJameel MuzaffarJohn C Morris IiiMabel RyderAlan L HoMark AgulnikLai WeiDemond HandleyCatherine MosesRajani JacobJohn WrightHoward StreicherWilliam CarsonManisha H ShahPublished in: The Journal of clinical endocrinology and metabolism (2024)
NCT03914300.